Arbutus Biopharma Corp (ABUS) — DEF 14A Filings
All DEF 14A filings from Arbutus Biopharma Corp. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Arbutus Biopharma Files Definitive Proxy Statement
— Apr 4, 2025 Risk: low
Arbutus Biopharma Corp filed a Definitive Proxy Statement (DEF 14A) on April 4, 2025, for its annual meeting on May 21, 2025. The filing concerns the solicitati -
Arbutus Biopharma Corp. Announces 2024 Annual General and Special Meeting
— Apr 10, 2024 Risk: low
Arbutus Biopharma Corp (ABUS) filed a Proxy Statement (DEF 14A) with the SEC on April 10, 2024. Arbutus Biopharma Corporation will hold its 2024 Annual General
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX